Rigel Pharmaceuticals (RIGL) Free Cash Flow Growth (3y) (2013 - 2026)
Rigel Pharmaceuticals (RIGL) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
553.93 Mn |
407.24 Mn |
54.21 Mn |
38.71% |
| Date | Value |
|---|
| Mar 31, 2026 |
38.71% |
| Dec 31, 2025 |
44.23% |
| Sep 30, 2025 |
55.79% |
| Jun 30, 2025 |
63.51% |
| Mar 31, 2025 |
67.44% |
| Dec 31, 2024 |
40.26% |
| Sep 30, 2024 |
59.68% |
| Jun 30, 2024 |
-82.34% |
| Mar 31, 2024 |
36.98% |
| Dec 31, 2023 |
27.05% |
| Sep 30, 2023 |
58.97% |
| Jun 30, 2023 |
34.33% |
| Mar 31, 2023 |
-3.26% |
| Dec 31, 2022 |
-28.92% |
| Sep 30, 2022 |
3.46% |
| Jun 30, 2022 |
8.43% |
| Mar 31, 2022 |
-201.24% |
| Dec 31, 2021 |
-53.93% |
| Sep 30, 2021 |
19.73% |
| Jun 30, 2021 |
58.48% |
